SKIL's Percipio drives soaring AI learning adoption and major workforce wins, strengthening its position in the evolving upskilling market.

Gladstone Capital has been one of my equity-focused BDC picks, which as opposed to FDUS and TRIN has delivered unpleasant returns. Recently, GLAD announced a dividend cut, which also came as a surprise to me. Yet, the Q4 2025 data points, in my view, indicate a clear turning point.

MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that its submission entitled “Reduced brain neuroinflammation after laromestrocel treatment in mild AD: results from the CLEAR MIND study” has been selected for a poster presentation at the 18th Clinical Trials on Alzheimer's Disease Conference (CTAD 2025) to be held December 1-4, 2025 in San Diego, CA. “We are excited to have been selected to present important laromestrocel data at this leading forum for Alzheimer's research and clinical investigation,” said Joshua …

AUSTIN, Texas, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that its Board of Directors has initiated a review of strategic alternatives in order to explore ways to maximize shareholder value. The review will include a range of potential actions, including raising equity capital, reverse mergers, combination transactions, and the sale of all or part of the Company's business, and other possible strategic or financial transactions.

SAN DIEGO , Nov. 19, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced its Managed Access Program (MAP) for investigational therapy delpacibart zotadirsen (del-zota) for eligible people with Duchenne muscular dystrophy mutations amenable to exon 44 skipping (DMD44) in the United States. "We recognize the considerable needs facing the DMD44 community given there are no approved exon skipping therapies for this disease as well as the potential of del-zota based on the unprecedented data shown in our clinical studies," said Sarah …

Nvidia stock price has pulled back in the past two weeks, moving from the year-to-date high of $212 to $180. This retreat will either accelerate or reverse once the company publishes its financial results later today.

Nearly $100,000 order demonstrates growing adoption of Actelis' networking solutions in Japan's rail sector Nearly $100,000 order demonstrates growing adoption of Actelis' networking solutions in Japan's rail sector

New York, New York--(Newsfile Corp. - November 19, 2025) - If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ: MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=178166&wire=5&utm_campaign=12 or contact Joseph E. Levi, Esq.

Rigetti Computing (RGTI) remains a 'Buy' due to its accelerated technology roadmap, commercial wins, and strong strategic positioning in quantum computing. RGTI's modular chiplet architecture and ambitious milestones, including a 1,000+ qubit system by 2027, differentiate it from competitors and add credibility. Recent commercial wins, including contracts with AFRL and partnerships with Nvidia, validate RGTI's technology and expand its growth opportunities.

M2i Global Inc (OTC:MTWO) and Volato Group have signed a memorandum of understanding (MOU) with Nimy Resources to pursue a supply agreement for gallium sourced from Western Australia, the companies announced on Wednesday. Under the non-binding MOU, Nimy and M2i plan to work toward commercially binding terms for the sale and purchase of gallium from Nimy's Mons Project.

WIX posts Q3 beat as 14% revenue growth and surging Base44 adoption push the company to raise full-year bookings and revenue guidance.

Valvoline (VVV) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.46 per share a year ago.

Viking Holdings (VIK) came out with quarterly earnings of $1.2 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $0.89 per share a year ago.

Not for distribution to U.S. news wire services or dissemination in the United States. THE BASE SHELF PROSPECTUS IS ACCESSIBLE, AND THE SHELF PROSPECTUS SUPPLEMENT FOR THE PUBLIC OFFERING AND ANY AMENDMENT TO THE DOCUMENTS WILL BE ACCESSIBLE, WITHIN TWO BUSINESS DAYS, THROUGH SEDAR+ BROOKFIELD, NEWS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Brookfield Corporation (“Brookfield”) (NYSE: BN, TSX: BN) today announced that it has agreed to issue 8,000,000 Class A Preference Shares, Series 54 (“Preferred Shares, Series 54”) on a bought deal basis to a syndicate of underwriters (the “Underwriters”) led by Scotiabank, BMO Capital Markets, CIBC Capital Markets, National …

Key Takeaways

Can a single stock take down the whole market? Here's what to know ahead of Nvidia's critical earnings.

META Platforms stock (NASDAQ: META) has declined by 18.4% within a span of 21 trading days. This significant drop indicates renewed worries among investors concerning the company's aggressive expenditure on both AI infrastructure and its Reality Labs division.

ARLINGTON, Va.--(BUSINESS WIRE)---- $AVAV--AeroVironment, Inc. (“AV”) (NASDAQ: AVAV) will participate in the upcoming Goldman Sachs' Industrials and Materials Conference in New York, New York. AV's chairman, president and chief executive officer, Wahid Nawabi, and AV's executive vice president and chief financial officer, Kevin McDonnell, will take part in a fireside chat on December 3 at 8:00 a.m. ET | 9:00 a.m. CT | 11:00 a.m. PT. The fireside chat will be available by webcast at the times listed above.

CHARLOTTE, N.C. , Nov. 19, 2025 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) today announced that Pascal Belaud will be the company's chief AI & data officer, starting Nov. 24.

Analysis continues to show merger will create long-term value, but current market volatility is cause to reevaluate alternatives in the future NEW YORK , Nov. 19, 2025 /PRNewswire/ -- Blue Owl Capital Corporation (NYSE: OBDC) ("OBDC") and Blue Owl Capital Corporation II ("OBDC II") today announced that the previously proposed merger of OBDC and OBDC II has been terminated, with plans to reevaluate alternatives in the future. This decision reflects the Boards' commitment to acting in the best interests of shareholders and is based on management's recommendation due to current market conditions.